Allergan (AGN) Initiates Qtr. Dividend at 70c/Share; Approves $10B to Stock Buyback Plan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Allergan (AGN) Misses Q3 EPS Views; Offers Pipeline, FY16 Guidance Updates
November 2, 2016 6:37 AM EDTAllergan (NYSE: AGN) reported Q3 EPS of $3.32, $0.26 worse than the analyst estimate of $3.58. Revenue for the quarter came in at $3.62 billion versus the consensus estimate of $3.69 billion.
New Dividend and Stock Buyback:
Allergan (NYSE: AGN) initiated a quarterly dividend of $0.70 per share, or $2.8 annualized. Yield is currently 1.3 percent.
Allergan also entered into a variable tenor accelerated share repurchase program (ASR) under which the Company will repurchase $10 billion of its ordinary shares.
Pipeline Update
Allergan R&D continued to build and deliver on... More
